Is Quantum Genomics SA halal to invest in?

According to Musaffa's Shariah screening methodology, Quantum Genomics SA (ALQGC.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Quantum Genomics SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Quantum Genomics SA using these criteria to determine its compliance status.

Can Muslims buy shares of Quantum Genomics SA?

Muslim investors may consider investing in Quantum Genomics SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Quantum Genomics SA classified as NOT HALAL?

Musaffa determines the Shariah status of Quantum Genomics SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Quantum Genomics SA updated?

The Shariah compliance status of Quantum Genomics SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Quantum Genomics SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Quantum Genomics SA?

You can check the latest Shariah compliance status of Quantum Genomics SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Quantum Genomics SA ALQGC.PA

€0.07 €0.00 (1.77%) 1D

Last Updated: Oct 24, 12:00 AM·XPAR

ALQGC.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 26, 2025

Report Source: 2024 Annual Report

Quantum Genomics SA. Stock Analysis ALQGC.PA

France Health Care Nano Cap Report: 2024 Annual

Quantum Genomics SA is a biopharmaceutical company, which engages in the development of therapies for cardiovascular diseases. The company is headquartered in Paris, Ile-De-France and currently employs 2 full-time employees. The company went IPO on 2009-07-28. The firm is a biopharmaceutical company dedicated to developing new therapies for unmet medical needs in cardiovascular disease, including high blood pressure and heart failure. Its main activity is in research and development of new therapies for the treatment of hypertension, BAPAI (Brain Aminopeptidase A Inhibitors) oriented in the field of cardiovascular diseases, especially high blood pressure and heart failure. The firm also co-develops products with academic teams, biotechnological research entities, and some of the pharmaceutical and bio-science companies. The firm is involved in four research programs. Quantum Genomics also collaborates with Center for Clinical Investigation 9201 APHP / INSERM of the Georges Pompidou European Hospital in Paris, among others.

Key Statistics of Quantum Genomics SA (ALQGC.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.07€0.07

Today's Open

€0.07

Volume

127.30K

P/E Ratio (TTM)

52 Week Range

€0.08€0.23

Market Cap

5.02M

Avg. Volume

1.95M

Dividend Yield

Financial Metrics & Statements of Quantum Genomics SA (ALQGC.PA)

FAQ's for Quantum Genomics SA (ALQGC.PA)

According to Musaffa’s Shariah screening methodology, Quantum Genomics SA (ALQGC.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.